Document is current
Any future updates will be listed below
-
Authors
Oswald, Laura B. https://orcid.org/0000-0001-6281-2512
Hyland, Kelly A.
Eisel, Sarah L.
Hoogland, Aasha I.
Knoop, Hans
Nelson, Ashley M.
Pinilla-Ibarz, Javier
Sweet, Kendra
Jacobsen, Paul B.
Jim, Heather S. L.
-
Funding
Funding for this research was provided by:
National Cancer Institute (R21-CA191594, P30-CA076292)
- License Information
-
More Information
Article History
Received: 29 March 2021
Accepted: 28 June 2021
First Online: 7 July 2021
Declarations
:
: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Chesapeake Institutional Review Board (Pro00023476).
: Informed consent to participate was obtained from all individual participants included in this study.
: All participants consented to having de-identified and aggregate study data published.
: Dr. Jim is a paid consultant for RedHill BioPharma, Janssen Scientific Affairs, and Merck. The other authors have no relevant conflicts of interest.
